InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Neervannan Seshadri. Director active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 12 reports have been recorded. Split: 0 buy · 7 sells. Total volume traded: €1.4m. History available since 17 March 2023. The latest transaction was disclosed on 4 September 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Neervannan Seshadri is a declarant linked to Tarsus Pharmaceuticals, Inc., where the listed role is Chief Operating Officer. He has 11 filings in total, and in the sampled recent filings the activity consists entirely of sales, with sell volume of EUR 1032757 between 2023-03-17 and 2026-03-24.